The Authors Reply:  by Udo, Kazuma & Toda, Shuji
The emerging concept of
a fibrotic microenvironment
in CKD
To the Editor: The elegant paper by Udo et al.,1 published in
the last issue of Kidney International, adds another relevant
piece of information to support the concept of the existence
of a ﬁbrotic microenvironment in chronic kidney disease
(CKD). A disease-perpetuating microenvironment is rather
an established concept in oncology, regarding which several
studies have shown that a tissue surrounding a carcinoma is
more than merely a scaffold on which the malignant cells rest,
but in fact plays an important interactive role with growth-
enhancing properties for the tumor.2,3 After overemphasis
on epithelial–mesenchymal transition, renal epithelial cells
emerge as phenotypes able to direct the biology, in an open
cross-talk through still unknown mediators, of the surround-
ing resident ﬁbroblasts and myoﬁbroblasts. Similarly to
carcinomas, wherein cancer cells can selectively induce
expression of alpha smooth muscle actin (a-SMA) in
surrounding stromal ﬁbroblasts, injured tubular epithelial
cells have been recently demonstrated4 to behave as a major
source of pro-inﬂammatory cytokines in experimental
induced kidney ﬁbrosis. Bonventre’s group4 showed that
unilateral ischemia induces G2/M arrest in proximal tubule
cells, resulting in abnormal ampliﬁcation of proﬁbrogenic
factors. In in vitro experiments, the same group showed that
enriched fractions of HK-2 cells in G2/M phase have
speciﬁcally higher mRNA levels of COL4A1 and ACTA2, the
latter gene encoding a-SMA, the hallmark of myoﬁbroblast
activation. Thus, the in vitro study by Udo et al., demonstrat-
ing that MDCK cells, but not 3T3 ﬁbroblasts, inhibit
regeneration of mesenchymal stem cells from adipose tissue
fragments, conﬁrms that renal tubular cells are able to
contribute to the general maintenance of the static state of
mesenchymal cells. These ﬁndings further corroborate the
relevance of deepening the scientiﬁc knowledge of regenera-
tion process mechanisms normally taking place in the kidney
after injury. Microarray, proteomics, and phosphoromic
applied to this speciﬁc question may open new possibilities
to design and create innovative drugs for CKD patients
preserving or inducing tubular epithelial cells toward a
healthy phenotype.
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The Authors Reply: We thank Drs Prunotto and Moll1 for
their remarks and for giving us the opportunity to describe
our comments. In our study,2 tubular cells inhibited
the regeneration of mesenchymal stem cells (MSCs) and
preadipocytes from adipose tissue (AT), while AT suppressed
and promoted the growth/apoptosis and differentiation of
tubular cells, respectively. Thus, tubular cells and AT mutually
regulate their homeostasis. As pointed out by Drs Prunotto
and Moll, the determination of the mediators for their
interaction would lead to the discovery of new molecules that
convert the abnormal phenotypes of tubular cells and
mesenchymal cell types to the normal phenotypes. This
may open up a new approach for CKD treatment. In general,
myoﬁbroblast phenotype seems to be critical for epithelial–-
mesenchymal interaction that occurs in the organogenesis,
tissue repair, and cancer. For example, cancer-associated
stromal cells such as ﬁbroblasts and MSCs gain myoﬁbroblast
phenotype.3 In our study (in submission), isolated AT stromal
cells (ATSCs) express myoﬁbroblast phenotype under the
interactions between ATSCs and epithelial cell types such as
tubular cells and cancer cells. Interestingly, ATSCs localized
within AT never express the myoﬁbroblast phenotype under
the interactions. This suggests that the biological behaviors of
cell types isolated from the tissue are different from those of
the cell types localized within the tissue regulated by the tissue
microenvironment even in vitro.
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